These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2393303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of recurrent cervical cancer].
    Takamizawa H, Kasai T, Arai T.
    Gan No Rinsho; 1983 Aug; 29(10):1079-84. PubMed ID: 6632194
    [Abstract] [Full Text] [Related]

  • 3. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG, Chen AS, Karasek K.
    Cancer J Sci Am; 1996 Aug; 2(5):256-62. PubMed ID: 9166542
    [Abstract] [Full Text] [Related]

  • 4. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, Hong JH.
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y.
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
    Kornovski Y, Gorchev G.
    J BUON; 2006 Jun; 11(3):291-7. PubMed ID: 17309152
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.
    Richel O, Zum Vörde Sive Vörding PJ, Rietbroek R, Van der Velden J, Van Dijk JD, Schilthuis MS, Westermann AM.
    Gynecol Oncol; 2004 Dec; 95(3):680-5. PubMed ID: 15581981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Perspectives and plans to improve the prognosis of cervical cancer].
    Sugimori H.
    Gan No Rinsho; 1990 Aug; 36(10):1187-91. PubMed ID: 1699002
    [Abstract] [Full Text] [Related]

  • 12. [Pelvic recurrence of cervical cancer: the prognostic relationship to the retreatment modalities].
    Zhang X, Zhang X, Liu A.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):611-3. PubMed ID: 8745509
    [Abstract] [Full Text] [Related]

  • 13. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B.
    Ann Acad Med Stetin; 2008 Oct; 54(1):28-40. PubMed ID: 19127807
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hyperthermia in combination with chemotherapy in gynecological cancers].
    Rietbroek RC, Schilthuis MS, van der Zee J, González González D.
    Ned Tijdschr Geneeskd; 1999 Jan 09; 143(2):85-8. PubMed ID: 10086110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Progress in the treatment of cervical cancer].
    Sugimori H.
    Gan To Kagaku Ryoho; 1988 Jun 09; 15(6):1840-6. PubMed ID: 3382236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.